Drawing for TARGETED PAIN TREATMENT - ACCURATE DIAGNOSIS AND TARGETED TREATMENT OF PAIN

USPTO serial 88057727

TARGETED PAIN TREATMENT - ACCURATE DIAGNOSIS AND TARGETED TREATMENT OF PAIN

Reviewed by CopyMark Law Group

Reg. 6043261Status 702Registered
Filing date
Status date
Registration date
Apr 28, 2020
Examiner
ABRAMS, JACQUELINE WILLETTE
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with TARGETED PAIN TREATMENT - ACCURATE DIAGNOSIS AND TARGETED TREATMENT OF PAIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

LaConya Murray

LaConya Murray Off The Mark Ip Solutions3966 Atlanta Hwy #221Montgomery, AL 36109United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable educational course materials in the field of accurate diagnosis of the cause of pain and targeting the treatment to the causeACTIVEFeb 1, 2019
041Educational services, namely, conducting conferences in the field of accurate diagnosis of the cause of pain and targeting the treatment to the cause and distribution of training material in connection therewithACTIVEFeb 1, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 4, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Aug 4, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Aug 4, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 28, 2026E815TEAS SECTION 8 & 15 RECEIVED—
Apr 28, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 14, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 14, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 14, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 28, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 24, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 24, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 21, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 21, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 21, 2020EX2GSOU EXTENSION 2 GRANTED—
Mar 19, 2020IUAFUSE AMENDMENT FILED—
Mar 19, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 19, 2020NREVNOTICE OF REVIVAL - E-MAILED—
Mar 19, 2020TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Mar 19, 2020PETGPETITION TO REVIVE-GRANTED—
Mar 19, 2020PROATEAS PETITION TO REVIVE RECEIVED—
Mar 16, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 16, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 12, 2020EXT2SOU EXTENSION 2 FILED—
Oct 8, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 7, 2019EX1GSOU EXTENSION 1 GRANTED—
Oct 7, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 20, 2019NREVNOTICE OF REVIVAL - E-MAILED—
Aug 20, 2019TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Aug 20, 2019PETGPETITION TO REVIVE-GRANTED—
Aug 20, 2019PROATEAS PETITION TO REVIVE RECEIVED—
Aug 12, 2019EXT1SOU EXTENSION 1 FILED—
Feb 12, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 18, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 18, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 28, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 14, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 9, 2018DOCKASSIGNED TO EXAMINER—
Aug 3, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 2, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance